Welcome to Gentronix
Gentronix provides services and solutions to help organisations optimise the development of drugs and other chemicals, by reducing attrition due to toxicity thus ensuring safer products across a wide range of chemistry driven industries.
Latest News Subscribe to our newsletter
New BlueScreen HC Publication from GSK
GlaxoSmithKline researchers have published a paper describing the miniaturisation and automation of the BlueScreen HC assay for use with 384 well plates.
First paper on use of BlueScreen HC accepted by “Journal of Biomolecular Screening” “Development of a high-throughput Gaussia luciferase reporter assay for the activation of the GADD45a gene by mutagens, promutagens, clastogens, and…
Gentronix Receives French Research Tax Credit Accreditation Gentronix Limited, the genotoxicity innovation and service company, is pleased to announce that it has received French research tax credit approval for years 2012 through 2014.